South Korea-based SK Bioscience has secured another approval for in-house vaccine. SK Bioscience obtained an export lic...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is providing funding of up to $19.3 million to suppo...
Jiangsu Recbio Technology Co., Ltd. has recently received the clinical trial approval for its recombinant protein COVID-...
Intravacc B.V., located at Utrecht Science Park Bilthoven in the Netherlands, has announced the signing o...
South Korea-based SK bioscience and GSK have announced submission of a biologics license application for SKYCovione a re...
GC Biopharma, based in South Korea, and Canadian firm Acuitas Therapeutics, a company focused on developing lipid nanopa...
On 20 April 2022, Sanofi launched Evolutive Vaccine Facility (EVF) in Singapore. A first-of-its-kind, the...
Takeda Pharma has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (M...
The International Vaccine Institute (IVI) and the Ministry of Health and Welfare (MOHW), Republic of Korea, have agreed ...
US-based Novavax, Inc. and Serum Institute of India have announced that the Thailand Food and Drug Administration (Thai ...
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation in Japan have announced the ...
Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...
CanSino Biologics has announced that the National Medical Products Administration of China (NMPA) granted approval for t...
A potential new approach to administering an existing Japanese encephalitis (JE) vaccine could make it more affordable a...
Singapore-based Prestige Biopharma and Vaxine have entered into a memorandum of understanding (MoU) to collabo...
Melbourne researchers are calling on healthy people aged 18-70 living in Victoria to roll up their sleeves for a Phase 1...
The Expert Committee on COVID-19 Vaccination (EC19V) in Singapore has been closely reviewing the data regarding the need...
The Australian government is investing more than $100 million for seasonal influenza vaccines to protect Aus...
